{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: RESULTS : Verapamil significantly increased PRL levels in healthy controls ( N . 8 , PRL : 183 % ) , macroprolactinoma ( N . 8 , PRL : 7 % ) , microprolactinoma ( N . 19 , PRL : 21 % ) , macroprolactinemia ( N . 23 , PRL : 126 % ) , but not in pseudoprolactinoma ( N . 8 , PRL : 0 . 8 % ) , and risperidone - induced hyperprolactinemia ( N . 7 , PRL : 3 % ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! Here are the \"Disease\" entities identified in the paragraph:\n\n| Disease |\n| --- |\n| Macroprolactinoma |\n| Microprolactinoma |\n| Macroprolactinemia |\n| Pseudoprolactinoma |\n| Risperidone-induced hyperprolactinemia |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Of course! Here are the valid \"Disease\" entities identified in the paragraph:\n\n| Disease |\n| --- |\n| Macroprolactinoma |\n| Microprolactinoma |\n| Macroprolactinemia |\n\nI have removed the following entities that do not clearly refer to \"Disease\":\n\n* Pseudoprolactinoma (this entity is not a recognized medical term)\n* Risperidone-induced hyperprolactinemia (this is a medical condition, but it is not a disease entity)"}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: RESULTS : Verapamil significantly increased PRL levels in healthy controls ( N . 8 , PRL : 183 % ) , macroprolactinoma ( N . 8 , PRL : 7 % ) , microprolactinoma ( N . 19 , PRL : 21 % ) , macroprolactinemia ( N . 23 , PRL : 126 % ) , but not in pseudoprolactinoma ( N . 8 , PRL : 0 . 8 % ) , and risperidone - induced hyperprolactinemia ( N . 7 , PRL : 3 % ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! Here are the \"Chemical\" entities mentioned in the paragraph:\n\n| Chemical |\n| --- |\n| Verapamil |\n| Macroprolactinoma |\n| Microprolactinoma |\n| Macroprolactinemia |\n| Pseudoprolactinoma |\n| Risperidone |\n| Prolactin (PRL) |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Of course! Here are the valid \"Chemical\" entities mentioned in the paragraph:\n\n| Chemical |\n| --- |\n| Verapamil |\n| Prolactin (PRL) |\n| Risperidone |\n\nI have removed the entities that do not clearly refer to \"Chemical\", such as \"macroprolactinoma\", \"microprolactinoma\", and \"macroprolactinemia\", as they are not chemical entities."}
  ]
}